| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/JNNP.55.10.869 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC1015179 |
| https://europepmc.org/articles/PMC1015179?pdf=render | ||
| P932 | PMC publication ID | 1015179 |
| P698 | PubMed publication ID | 1431949 |
| P5875 | ResearchGate publication ID | 21723666 |
| P2093 | author name string | D. H. Miller | |
| A. Feinstein | |||
| M. A. Ron | |||
| B. D. Youl | |||
| L. D. Kartsounis | |||
| P2860 | cites work | Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS) | Q22241644 |
| The hospital anxiety and depression scale | Q27860968 | ||
| Deficient learning and memory in early and middle phases of multiple sclerosis | Q33619519 | ||
| A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow-up | Q33628639 | ||
| A standardized psychiatric interview for use in community surveys | Q33699953 | ||
| New diagnostic criteria for multiple sclerosis: guidelines for research protocols | Q34271601 | ||
| Neuropsychological assessment in patients with relapsing-remitting multiple sclerosis and mild functional impairment: correlation with magnetic resonance imaging | Q36933877 | ||
| Mental change as an early feature of multiple sclerosis | Q37047389 | ||
| Acute optic neuritis: prognosis for development of multiple sclerosis | Q37130376 | ||
| Guidelines for neuropsychological research in multiple sclerosis | Q38137831 | ||
| Affective disorders in multiple sclerosis. Review and recommendations for clinical research | Q38137832 | ||
| Amnesia: a disconnection syndrome? | Q38499953 | ||
| Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis | Q44043791 | ||
| The relation between physical, psychological, and social morbidity in a suburban community | Q44669527 | ||
| Structural brain correlates of emotional disorder in multiple sclerosis | Q45143536 | ||
| The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study | Q48177147 | ||
| Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test | Q48184614 | ||
| A modified card sorting test sensitive to frontal lobe defects | Q48346552 | ||
| Cognitive abnormalities in multiple sclerosis: a psychometric and MRI study | Q48798566 | ||
| Preserved recall versus impaired recognition. A case study | Q48920800 | ||
| Psychiatric morbidity in multiple sclerosis: a clinical and MRI study. | Q52062391 | ||
| Correlation of neuropsychological and MRI findings in chronic/progressive multiple sclerosis. | Q52068343 | ||
| Cognitive disturbances in patients with relapsing remitting multiple sclerosis. | Q52113272 | ||
| Cognitive impairment in patients with clinically isolated lesions of the type seen in multiple sclerosis. A psychometric and MRI study. | Q52116426 | ||
| Cognitive dysfunction and change in multiple sclerosis. | Q52123119 | ||
| Multiple memory deficits in patients with multiple sclerosis. Exploring the working memory system. | Q52123560 | ||
| Psychiatric Illness in General Practice: A Detailed Study Using a New Method of Case Identification | Q52124252 | ||
| Magnetic resonance imaging correlates of dementia in multiple sclerosis. | Q52130347 | ||
| Memory disturbance in chronic progressive multiple sclerosis. | Q52210743 | ||
| Neuropsychological test performance as a function of the duration of MS-related symptomatology | Q52236876 | ||
| Cognition in patients with multiple sclerosis After four years. | Q52239776 | ||
| Cognitive impairment in patients with multiple sclerosis and mild physical disability. | Q52256834 | ||
| Wisconsin Card Sorting Test performance in relapsing-remitting and chronic-progressive multiple sclerosis. | Q52257079 | ||
| Major differences in the dynamics of primary and secondary progressive multiple sclerosis | Q68201259 | ||
| Psychiatric morbidity in patients with clinically isolated lesions of the type seen in multiple sclerosis: a clinical and MRI study | Q68458112 | ||
| Depression in multiple sclerosis | Q69469537 | ||
| The early risk of multiple sclerosis following isolated acute syndromes of the brainstem and spinal cord | Q69802872 | ||
| Neuropsychological findings in relapsing-remitting and chronic-progressive multiple sclerosis | Q70074314 | ||
| Disability and intellectual function in multiple sclerosis patients | Q71442251 | ||
| Abnormalities in the macroscopically normal white matter in cases of mild or spinal multiple sclerosis (MS) | Q72003895 | ||
| Effect of high haematocrit on alertness | Q72422874 | ||
| An investigation of physical and intellectual changes in multiple sclerosis | Q72776764 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple sclerosis | Q8277 |
| magnetic resonance imaging | Q161238 | ||
| neuropsychological test | Q3818443 | ||
| P304 | page(s) | 869-876 | |
| P577 | publication date | 1992-10-01 | |
| P1433 | published in | Journal of Neurology, Neurosurgery and Psychiatry | Q1599804 |
| P1476 | title | Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive, psychiatric, and MRI follow up study | |
| P478 | volume | 55 |
| Q57911892 | A longitudinal study of cognition in primary progressive multiple sclerosis |
| Q33734435 | Attention related performance in two cognitively different subgroups of patients with multiple sclerosis |
| Q41888893 | Brain magnetic resonance imaging and multimodal evoked potentials in benign and secondary progressive multiple sclerosis. |
| Q51954309 | Changes of attention and memory in a group of patients with multiple sclerosis. |
| Q52602975 | Childhood MS and ADEM: investigation and comparison of neurocognitive features in children. |
| Q28246535 | Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis |
| Q64070095 | Cognitive Impairment in Multiple Sclerosis With Regards to Disease Duration and Clinical Phenotypes |
| Q31117463 | Cognitive disorders in multiple sclerosis |
| Q44107313 | Cognitive dysfunction 24-31 years after isolated optic neuritis. |
| Q32129064 | Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management |
| Q51921613 | Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis. |
| Q48553216 | Cognitive dysfunction in primary progressive multiple sclerosis: a neuropsychological and MRI study |
| Q42290241 | Cognitive evolution in natalizumab-treated multiple sclerosis patients |
| Q35487283 | Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis |
| Q51018033 | Cognitive impairment at the onset of multiple sclerosis: relationship to lesion location. |
| Q38942621 | Cognitive impairment in MS: rehabilitation approaches |
| Q47124802 | Cognitive impairment in clinically isolated syndrome: A systematic review |
| Q28270988 | Cognitive impairment in multiple sclerosis |
| Q47135520 | Cognitive impairment in patients with clinically isolated syndrome. |
| Q24672050 | Cognitive impairment in probable multiple sclerosis |
| Q51970002 | Cognitive impairment in relapsing-remitting multiple sclerosis can be predicted by imaging performed several years earlier. |
| Q51033613 | Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome |
| Q48321985 | Cognitive impairment is correlated with reduced quality of life in patients with clinically isolated syndrome. |
| Q48169667 | Computerised volumetric analysis of lesions in multiple sclerosis using new semi-automatic segmentation software |
| Q36804965 | Depression associated with multiple sclerosis: an etiological conundrum |
| Q46098483 | Detecting cognitive dysfunction in a busy multiple sclerosis clinical setting: a computer generated approach |
| Q51533694 | Diffusion tensor imaging abnormalities in cognitively impaired multiple sclerosis patients |
| Q38399474 | Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis |
| Q37645629 | Early treatment of multiple sclerosis: a Latin American experts meeting |
| Q48831135 | Evaluating sub-clinical cognitive dysfunction and event-related potentials (P300) in clinically isolated syndrome. |
| Q28296175 | Exercise and multiple sclerosis |
| Q48956745 | Functional magnetic resonance imaging correlates of cognitive performance in patients with a clinically isolated syndrome suggestive of multiple sclerosis at presentation: an activation and connectivity study. |
| Q43716194 | Influence of the topography of brain damage on depression and fatigue in patients with multiple sclerosis |
| Q38212034 | Is neuropsychological rehabilitation effective in multiple sclerosis? |
| Q34146255 | Is the concept of quality of life relevant for multiple sclerosis patients with cognitive impairment? Preliminary results of a cross-sectional study |
| Q48704199 | Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome |
| Q48277250 | Longitudinal evaluation of depression and anxiety in patients with clinically isolated syndrome at high risk of developing early multiple sclerosis |
| Q35475021 | Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings |
| Q52139071 | MR imaging quantitation of gray matter involvement in multiple sclerosis and its correlation with disability measures and neurocognitive testing. |
| Q46959470 | Mood and coping in clinically isolated syndrome and multiple sclerosis. |
| Q34220348 | Multiple sclerosis masquerade |
| Q33798227 | Multiple sclerosis: the disease and its manifestations |
| Q34680959 | Myelin, copper, and the cuprizone model of schizophrenia |
| Q50761855 | Negative affect predicts subsequent cognitive change in multiple sclerosis. |
| Q33973458 | Neurocognitive outcome after acute disseminated encephalomyelitis |
| Q49076412 | Neuropathology of cognitive dysfunction in multiple sclerosis |
| Q48433717 | Neuropsychological aspects of multiple sclerosis |
| Q40864839 | Neuropsychological aspects of multiple sclerosis: a quantitative review |
| Q41622010 | Neuropsychological assessment in multiple sclerosis: methodological issues and concerns |
| Q24200424 | Neuropsychological rehabilitation for multiple sclerosis |
| Q24234991 | Neuropsychological rehabilitation for multiple sclerosis |
| Q24235230 | Neuropsychological rehabilitation for multiple sclerosis |
| Q46990771 | New brain lesions with no impact on physical disability can impact cognition in early multiple sclerosis: A ten-year longitudinal study. |
| Q80793535 | One-year follow-up study of relapsing-remitting MS patients' cognitive performances: Paced Auditory Serial Addition Test's susceptibility to change |
| Q58152410 | Performance of subjects with multiple sclerosis on tests of high-level language |
| Q39774100 | Prescribed psychiatric medication among multiple sclerosis patients before and after disability pension: a register study with matched controls |
| Q36086116 | Prevalence and risk factors for depression in women with multiple sclerosis: a study from Iran |
| Q43769945 | Psychiatric comorbidity in pediatric patients with demyelinating disorders |
| Q37704428 | Reduced magnetisation transfer ratio in cognitively impaired patients at the very early stage of multiple sclerosis: a prospective, multicenter, cross-sectional study. |
| Q48707110 | Relationship between global cognitive decline and depressive symptoms in multiple sclerosis |
| Q31108979 | Relevance of quality of life assessment for multiple sclerosis patients with memory impairment |
| Q49121991 | Resolution of left hemisphere cognitive dysfunction in multiple sclerosis with magnetic resonance correlates: a case report |
| Q49041541 | Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study |
| Q51949583 | The influence of folate serum levels on depressive mood and mental processing in patients with epilepsy treated with enzyme-inducing anti-epileptic drugs. |
| Q38238940 | The link between multiple sclerosis and depression |
| Q37710112 | The neuropsychiatry of multiple sclerosis: focus on disorders of mood, affect and behaviour |
| Q30660682 | The neuropsychology of multiple sclerosis: contributions of neuroimaging research |
| Q39635811 | Voxelwise analysis of conventional magnetic resonance imaging to predict future disability in early relapsing-remitting multiple sclerosis |
| Q79938853 | [Contribution of cognitive evoked potentials for detecting early cognitive disorders in multiple sclerosis] |
| Q83636839 | [Depression in multiple sclerosis] |
| Q52575497 | [Early detection of cognitive impairment in relapsing-remitting multiple sclerosis: functional-anatomical correlations and longitudinal follow-up] |
| Q52017437 | [From psychometry to neuropsychological disability in multiple sclerosis: a new brief French cognitive screening battery and cognitive risk factors] |
Search more.